Boehringer Ingelheim

FDA approves Boehringer's once-a-day inhaler drug
Yahoo/AP
Thu, 07/31/14 - 03:58 pm
FDA
Boehringer Ingelheim
Striverdi Respimat
COPD
J&J builds 9-month supply of Doxil with creative problem solving
Fierce Pharma
Fri, 07/25/14 - 05:59 pm
JNJ
Boehringer Ingelheim
Doxil
drug shortage
Janssen
ovarian cancer
Did Boehringer Ingelheim Withhold Pradaxa Data From Regulators?
WSJ Online
Wed, 07/23/14 - 06:29 pm
Pradaxa
Boehringer Ingelheim
Boehringer cancer drug effective in mid-stage trial
Reuters
Tue, 07/8/14 - 10:26 am
Boehringer Ingelheim
acute myeloid leukemia
volasertib
NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thu, 06/19/14 - 10:36 am
NICE
Pradaxa
Xarelto
bloodthinners
Eliquis
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Boehringer Ingelheim
FirstWord List: Top 15 pharma and lead product dependency
First Word Pharma
Mon, 06/9/14 - 10:35 am
Teva
AbbVie
Boehringer Ingelheim
GSK
Sanofi
Amgen
Eli Lilly
JNJ
AstraZeneca
Roche
Novartis
Merck
Pfizer
Takeda
Bristol-Myers Squibb
Boehringer Ingelheim to sell US injectable generics business to Hikma for up to $300 million
First Word Pharma
Wed, 05/28/14 - 10:07 am
Boehringer Ingelheim
Hikma
injectables
M&A
Boehringer to settle lawsuits against blockbuster drug for $650 mln
Yahoo/Reuters
Wed, 05/28/14 - 09:42 am
Boehringer Ingelheim
Pradaxa
Novartis, Boehringer vie for COPD market share with combo meds
Fierce Biotech
Thu, 05/22/14 - 11:57 am
COPD
Novartis
Boehringer Ingelheim
LAMA/LABA
Boehringer Ingelheim to Make Clinical Trial Data Available
PharmTech
Sat, 05/17/14 - 10:18 am
Boehringer Ingelheim
Biotech Stock Mailbag: Previewing InterMune's Big Week Ahead
TheStreet.com
Fri, 05/16/14 - 10:07 am
InterMune
IPF
idiopathic pulmonary fibrosis
Boehringer Ingelheim
pirfenidone
nintedanib
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Warfarin's Loss is Johnson & Johnson's Gain
Motley Fool
Mon, 04/21/14 - 04:20 pm
JNJ
bloodthinners
Warfarin
Pradaxa
Xarelto
Boehringer Ingelheim
Eli Lilly/ Boehringer Drug Under FDA Review
Yahoo/Zacks.com
Tue, 04/15/14 - 04:49 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trajenta
empagliflozin
diabetes
type 2 diabetes
Boehringer 2013 profit up on Pradaxa sales, cost cuts
Reuters
Tue, 04/15/14 - 10:37 am
earnings
Boehringer Ingelheim
Boehringer Ingelheim's Oral Anticoagulant Gains New Indication
Forbes
Mon, 04/7/14 - 12:57 pm
Boehringer Ingelheim
anticlotting
Pradaxa
deep venous thrombosis
DVT
pulmonary embolism
Boehringer, Lilly Diabetes Drug Wins EU Panel’s Backing
Bloomberg
Fri, 03/21/14 - 09:41 am
Jardiance
diabetes
Boehringer Ingelheim
Eli Lilly
Europe
InterMune Rises on Takeover Rumour
Yahoo/Zacks.com
Mon, 03/10/14 - 05:05 pm
M&A
InterMune
Sanofi
Esbriet
Boehringer Ingelheim
Novartis
Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Pharmabiz
Sat, 03/8/14 - 10:49 am
SVR12
Boehringer Ingelheim
HCV
HIV
hepatitis
hepatitis C
What Does This Rejection Mean for Eli Lilly?
Motley Fool
Fri, 03/7/14 - 09:24 am
Eli Lilly
FDA
empagliflozin
Boehringer Ingelheim

Pages